DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "North America COPD & Asthma Devices Market (2016-2022)" report to their offering.
Increasing prevalence of respiratory diseases owing to the growing aging population and increasing pathogens in the environment has been the key factor driving the asthma and chronic obstructive pulmonary disease (COPD) market globally. Asthma & COPD are chronic respiratory diseases that are either genetically acquired or caused due to several environmental factors. These diseases are supposed to be non-curable, but may be controlled to a great extent with proper on-time diagnosis. The North America market for Asthma & COPD has been analyzed on the basis of drugs and devices used for these diseases. Key drugs employed for control and diagnosis of asthma and COPD may be classified on the basis of their types which include bronchodilators, leukotriene antagonists, mast cell stabilizers and immunosuppressants.
The report highlights the adoption of COPD & Asthma Devices in North America. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The countries included in the report are U.S, Canada, Mexico and Rest of North America.
Key Topics Covered:
1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
1.5 Research Methodology
2. North America COPD and Asthma Devices Market Overview
2.2 Key Influencing Factors
2.3 North America COPD & Asthma Device Market
3. North America COPD and Asthma Device Market - By Product Type
4. North America COPD & Asthma Device Market - By Country
5. Company Profiles
- Glaxosmithcline PLC
- Novartis International AG
- Merck & Co., Inc.
- AstraZeneca Plc
- 3M Healthcare
- GF Health Products, Inc
- Sunovion Pharmaceuticals Inc.
- Koninklijke Philips N.V.
- Smith Medicals, Inc.
- Baxter International
For more information about this report visit http://www.researchandmarkets.com/research/pqvzr7/north_america